New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 (‘Blue Mystic’)
暂无分享,去创建一个
Fabrizio Schifano | Giovanni Martinotti | Paolo Deluca | G. Martinotti | F. Schifano | P. Deluca | J. Corkery | Lisa Agosti | John M. Corkery | Lisa Agosti
[1] J. Halpern. Hallucinogens: An update , 2003, Current psychiatry reports.
[2] J. Sklerov,et al. A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-EI-MS and HPLC-electrospray-MS. , 2004, Journal of analytical toxicology.
[3] I. Bosman,et al. A new trend in drugs-of-abuse; the 2C-series of phenethylamine designer drugs , 2004, Pharmacy World and Science.
[4] Christopher R. Wolfe,et al. Learning and Teaching on the World Wide Web , 2001 .
[5] E. sanders-Bush,et al. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. , 1988, The Journal of pharmacology and experimental therapeutics.
[6] G. Aghajanian,et al. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex. , 1996, The Journal of pharmacology and experimental therapeutics.
[7] Fabrizio Schifano,et al. Importance of Cyberspace for the Assessment of the Drug Abuse Market: Preliminary Results from the Psychonaut 2002 Project , 2003, Cyberpsychology, Behavior, and Social Networking.
[8] P. Wax. Just a click away: recreational drug Web sites on the Internet. , 2002, Pediatrics.
[9] R. Glennon. Do classical hallucinogens act as 5-HT2 agonists or antagonists? , 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[10] A. Balestrieri,et al. Acquired and crossed tolerance to mescaline, LSD-25, and BOL-148. , 1959, A.M.A. archives of general psychiatry.
[11] J. Gewirtz,et al. Behavioral Evidence for Interactions between a Hallucinogenic Drug and Group II Metabotropic Glutamate Receptors , 2000, Neuropsychopharmacology.
[12] A. Shulgin,et al. Structure-activity relationships of the classic hallucinogens and their analogs. , 1994, NIDA research monograph.
[13] Robert G Carlson,et al. Sources of information about MDMA (3,4-methylenedioxymethamphetamine): perceived accuracy, importance, and implications for prevention among young adult users. , 2004, Drug and alcohol dependence.
[14] R. Glennon,et al. Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens , 2004, Psychopharmacology.
[15] Fabrizio Schifano,et al. Internet pharmacies and online prescription drug sales: a cross-sectional study , 2005 .
[16] P. Kemp,et al. Postmortem identification and quantitation of 2,5-dimethoxy-4-n-propylthiophenethylamine using GC-MSD and GC-NPD. , 2003, Journal of analytical toxicology.
[17] Giuseppe Riva,et al. From real to Virtual Communities: Cognition, Knowledge, and Intention in the World Wide Web , 2001 .
[18] F. Vollenweider. Advances and Pathophysiological Models of Hallucinogenic Drug Actions in Humans: A Preamble to Schizophrenia Research , 1998, Pharmacopsychiatry.
[19] G. Aghajanian,et al. Serotonin and Hallucinogens , 1999, Neuropsychopharmacology.
[20] E. sanders-Bush,et al. Agonist-Directed Signaling of Serotonin 5-HT2C Receptors: Differences Between Serotonin and Lysergic Acid Diethylamide (LSD) , 1999, Neuropsychopharmacology.